Τετάρτη 23 Μαΐου 2018

Senescent cells re‐engineered to express soluble programmed death receptor‐1 for inhibiting programmed death receptor‐1/programmed death ligand‐1 as a vaccination approach against breast cancer

Cancer Science, EarlyView.


https://ift.tt/2IJB4fe

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου